Tim Bartels Selected Research

c-Mer Tyrosine Kinase

9/2023

MerTK is a mediator of alpha-synuclein fibril uptake by human microglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Bartels Research Topics

Disease

21	Parkinson Disease (Parkinson's Disease) 09/2023 - 10/2010
9	Synucleinopathies 09/2023 - 08/2011
7	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2023 - 10/2010
6	Dementia (Dementias) 09/2023 - 02/2016
1	Lewy Body Disease (Lewy Body Dementia) 09/2023
1	Multiple System Atrophy 01/2021
1	Proteostasis Deficiencies 01/2018
1	Tauopathies 01/2018
1	Asthma (Bronchial Asthma) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014

Drug/Important Bio-Agent (IBA)

20	SynucleinsIBA 01/2023 - 10/2010
9	Proteins (Proteins, Gene)FDA Link 09/2023 - 10/2010
2	alpha-SynucleinIBA 09/2023 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
1	Protein AggregatesIBA 09/2023
1	RNA (Ribonucleic Acid)IBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	c-Mer Tyrosine KinaseIBA 09/2023
1	OligosaccharidesIBA 01/2023
1	G(M1) GangliosideIBA 01/2023
1	PrionsIBA 01/2022
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2017
1	Peptides (Polypeptides)IBA 02/2016

Therapy/Procedure

1	Therapeutics 10/2020